BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15888932)

  • 1. CARE-2 fingerprinting of Candida albicans isolates.
    Morschhäuser J; Staib P; Köhler G
    Methods Mol Med; 2005; 118():27-34. PubMed ID: 15888932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 prime].
    Wang YB; Wang H; Guo HY; Zhao YZ; Luo SQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1303-6. PubMed ID: 14678897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
    J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil.
    Goldman GH; da Silva Ferreira ME; dos Reis Marques E; Savoldi M; Perlin D; Park S; Godoy Martinez PC; Goldman MH; Colombo AL
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):25-32. PubMed ID: 15380275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on experimental induction of fluconazole resistance in Candida albicans].
    Zhu YN; Lu SM
    Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):418-22. PubMed ID: 15636370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clade-related amphotericin B resistance among South African Candida albicans isolates.
    Blignaut E; Molepo J; Pujol C; Soll DR; Pfaller MA
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):29-31. PubMed ID: 16182076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
    Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans switch phenotypes display differential levels of fitness.
    Vargas K; Srikantha R; Holke A; Sifri T; Morris R; Joly S
    Med Sci Monit; 2004 Jul; 10(7):BR198-206. PubMed ID: 15232493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole resistance in Candida albicans: a review of mechanisms.
    Casalinuovo IA; Di Francesco P; Garaci E
    Eur Rev Med Pharmacol Sci; 2004; 8(2):69-77. PubMed ID: 15267120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of candidemia in a Turkish tertiary care hospital.
    Bakir M; Cerikcioglu N; Barton R; Yagci A
    APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
    Jacobsen MD; Boekhout T; Odds FC
    FEMS Yeast Res; 2008 Aug; 8(5):764-70. PubMed ID: 18547330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
    MacNeill C; Weisz J; Carey JC
    J Reprod Med; 2003 Feb; 48(2):63-8. PubMed ID: 12621787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.